HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 2,437-2,448 of 7,264
Other study type icon
CompletedNCT03920475

The Role of Inflammatory Processes in Development and Treatment of Depression

Official study title

An Investigation of the Role of Inflammatory Processes in the Development and Treatment of Idiopathic Unipolar and Bipolar Depression in Patients With Moderate to Severe Depressive Symptoms.

This study has finished and is no longer accepting participants.

Location not clearly listed
DepressionObservational studyAges 18–65
Countries
Sponsor
Kliniken Essen-Mitte
Drug study icon
Active Not RecruitingNCT04950868

Effectiveness of quetiapine in depression

What is this study about?

This study evaluates the safety and effectiveness of Quetiapine for people with depression.

This study is no longer accepting new participants.

In London
DepressionMedication studyAges 18–45
Countries
Canada
Sponsor
Verinder Sharma
Behavioral study icon
CompletedNCT05110456

Effectiveness of virtual and Telephone Intervention in depression

Official study title

Starting Before Birth to Prevent Maternal Mental Health Problems: "Parents and Babies" Program (Programme "Toi, Moi, Bébé")

This study has finished and is no longer accepting participants.

In Montreal
DepressionBehavioural studyAges 14+
Countries
Canada
Sponsor
St. Justine's Hospital
Device study icon
CompletedNCT05551585

Transcranial Pulse Stimulation for Depression

Official study title

A Randomized, Double-blind, Sham-controlled Clinical Trial of Transcranial Pulse Stimulation for the Treatment of Major Depression

This study has finished and is no longer accepting participants.

In Hong Kong
DepressionDevice studyAges 18–65
Countries
China
Sponsor
The Hong Kong Polytechnic University
Drug study icon
TerminatedNCT00867360

Treatment of Psychotic Major Depression With Mifepristone

What is this study about?

Researchers are comparing Mifepristone (RU-486) and placebo to find out how the approaches affect psychotic symptoms in people with depression.

This study ended early.

In Stanford
Depression, SchizophreniaMedication studyAges 21–85
Countries
United States
Sponsor
Stanford University
Drug study icon
Recruitment unclearEUCTR 2021-005992-38

A randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy, safety, tolerability, and pharmacokinetics of single subcutaneous MIJ821 injection in addition to stan...

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Poland
DepressionHistorical research record
Countries
Poland, Spain
Sponsor
Novartis Farmacéutica, S.A.
Drug study icon
CompletedNCT03039192

Intranasal Esketamine for depression

What is this study about?

This study evaluated the safety and effectiveness of Esketamine for people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
Depression, SuicidalityMedication studyAges 18–64
Countries
United States, Bulgaria, Estonia, + 8 others
Sponsor
Janssen Research & Development, LLC

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.